lncRNA Blog lncRNA Research and Industry News

HAYA Therapeutics is a precision therapeutics company that discovers and develops innovative tissue- and cell-selective genomic medicines for fibrotic diseases and other serious health...

Scientists recently reported the key role of histone acetylation-regulated long noncoding RNA termed as lysosome cell death regulator (LCDR) in tumor survival, providing a potential diagnostic and therapeutic target for lung cancer.Led by Prof. GAO Shan...

Fungi of the Candida genus cause diseases such as vaginal candidiasis (highly prevalent but not serious) and systemic candidiasis (rare but can be fatal in immunocompromised patients). Although some...

Skeletal muscle displays remarkable plasticity upon exercise, but is at the same time one of our organs that is most affected by aging. Skeletal muscle aging is characterized by estimated yearly losses of ~1% muscle mass and ~3% muscle strength in the elderly...

Catalogue of 166 biomarkers generated through machine learning analysis of long non-coding RNAs A new batch of prognostic cancer biomarkers have...

A study from Washington University School of Medicine in St. Louis has identified an long non-coding RNA molecule that suppresses prostate tumors...

is abundantly expressed in cardiomyocytes. They showed that it enhances energy production by...